Eli Lilly and Co
SWB:LLY

Watchlist Manager
Eli Lilly and Co Logo
Eli Lilly and Co
SWB:LLY
Watchlist
Price: 914.3 EUR 0.96% Market Closed
Market Cap: 869B EUR

Relative Value

The Relative Value of one LLY stock under the Base Case scenario is hidden EUR. Compared to the current market price of 914.3 EUR, Eli Lilly and Co is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LLY Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
23
vs Industry
9
Median 3Y
16.1
Median 5Y
13.1
Industry
2.6
Forward
15.8
vs History
44
vs Industry
5
Median 3Y
69.1
Median 5Y
54.3
Industry
21.7
Forward
44.6
vs History
42
vs Industry
5
Median 3Y
81.4
Median 5Y
50.8
Industry
16.7
vs History
53
vs Industry
5
Median 3Y
84.2
Median 5Y
62.8
Industry
23.1
vs History
34
vs Industry
0
Median 3Y
46.5
Median 5Y
35.3
Industry
2.2
vs History
23
vs Industry
8
Median 3Y
16.6
Median 5Y
13.7
Industry
2.9
Forward
16.3
vs History
25
vs Industry
9
Median 3Y
20.7
Median 5Y
16.5
Industry
5.5
vs History
38
vs Industry
7
Median 3Y
47.2
Median 5Y
33.9
Industry
13.2
Forward
36.5
vs History
47
vs Industry
8
Median 3Y
54.1
Median 5Y
39.1
Industry
16.8
Forward
39.1
vs History
42
vs Industry
5
Median 3Y
84.1
Median 5Y
52.7
Industry
15.9
vs History
6
vs Industry
0
Median 3Y
-190.3
Median 5Y
46.5
Industry
19.2
vs History
25
vs Industry
8
Median 3Y
9.8
Median 5Y
8.1
Industry
1.9

Multiples Across Competitors

LLY Competitors Multiples
Eli Lilly and Co Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Eli Lilly and Co
SWB:LLY
1T EUR 17.1 55.1 36.9 39.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
495.1B USD 5.4 19.7 16.1 20.9
CH
Roche Holding AG
SIX:ROG
262.5B CHF 4.3 27.8 11.9 13.9
UK
AstraZeneca PLC
LSE:AZN
213B GBP 4.9 30.6 108.9 159.4
CH
Novartis AG
SIX:NOVN
211.3B CHF 4.8 18.6 11.8 15.2
US
Merck & Co Inc
NYSE:MRK
261.3B USD 4.1 13.7 9.8 11.6
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK 4.7 14.2 9.9 11.5
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
141.5B USD 2.3 14.4 7.4 10.1
FR
Sanofi SA
PAR:SAN
100.1B EUR 1.5 7.3 6.6 6.6
P/E Multiple
Earnings Growth PEG
US
Eli Lilly and Co
SWB:LLY
Average P/E: 22.4
55.1
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.7
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.8
29%
1
UK
AstraZeneca PLC
LSE:AZN
30.6
38%
0.8
CH
Novartis AG
SIX:NOVN
18.6
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.7
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
14.2
4%
3.5
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.4
29%
0.5
FR
Sanofi SA
PAR:SAN
7.3
26%
0.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Eli Lilly and Co
SWB:LLY
Average EV/EBITDA: 399.7
36.9
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.1
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.9
4%
3
UK
AstraZeneca PLC
LSE:AZN
108.9
10%
10.9
CH
Novartis AG
SIX:NOVN
11.8
6%
2
US
Merck & Co Inc
NYSE:MRK
9.8
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.9
2%
5
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
1%
7.4
FR
Sanofi SA
PAR:SAN
6.6
8%
0.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Eli Lilly and Co
SWB:LLY
Average EV/EBIT: 1 711
39.6
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.9
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.9
5%
2.8
UK
AstraZeneca PLC
LSE:AZN
159.4
23%
6.9
CH
Novartis AG
SIX:NOVN
15.2
12%
1.3
US
Merck & Co Inc
NYSE:MRK
11.6
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
11.5
1%
11.5
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.1
8%
1.3
FR
Sanofi SA
PAR:SAN
6.6
15%
0.4